Literature DB >> 33991509

Inhaled budesonide for early treatment of COVID-19 - Authors' reply.

Sanjay Ramakrishnan1, Mona Bafadhel2.   

Abstract

Entities:  

Year:  2021        PMID: 33991509     DOI: 10.1016/S2213-2600(21)00212-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  1 in total

Review 1.  [Recommendations for use of topical inhalant budesonide in COVID-19 : A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German version].

Authors:  Ludger Klimek; Roland Buhl; Thomas Deitmer; Stefan Plontke; Wolfgang Wehrmann; Hans Merk; Johannes Ring; Sven Becker
Journal:  HNO       Date:  2021-06-17       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.